ReviewClinical kidney journal2025
The role of obinutuzumab in rituximab-refractory membranous nephropathy and minimal change disease.
Zewei Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it